Tag: PFA

Cardiac Rhythm News’ top stories of 2024

From first-time clinical data to major industry debuts, here are Cardiac Rhythm News’ 10 most popular stories of 2024. 1. Abbott joins the pulsed field...

BTL Medical announces successful first-in-human treatments with novel PFA catheter

BTL Medical has announced the successful treatment of the first six patients in a first-in-human feasibility study using its next-generation catheter system designed to...

Pulse appoints David Kenigsberg as Electrophysiology CMO and adds Andrea Natale...

Pulse Biosciences has announced the appointment of David Kenigsberg (Florida Heart Rhythm Specialists, Fort Lauderdale, USA) as chief medical officer (CMO) of Electrophysiology. In...

J&J MedTech receives US FDA approval for Varipulse PFA platform in...

Johnson & Johnson (J&J) MedTech has announced the US Food and Drug Administration (FDA) approval of the Varipulse pulsed field ablation (PFA) platform for...

MedLumics treats first 10 patients in AblaView clinical study and announces...

MedLumics recently announced that 10 patients have been treated in the company’s first-in-man clinical trial, which is ongoing and currently under protocol-dictated follow-up. The...

Boston Scientific launches next generation of cardiac mapping for Farapulse PFA...

Boston Scientific Corporation has announced that it has received US Food and Drug Administration (FDA) approval of the navigation-enabled Farawave Nav ablation catheter for...

Abbott progresses PFA clinical studies, launches new advanced cardiac mapping technology

Abbott announced today that it has achieved new, major milestones to support the company's growing suite of pulsed field ablation (PFA) solutions in electrophysiology. These...

Boston Scientific receives Japanese regulatory approval for Farapulse PFA system

Boston Scientific has announced receipt of Pharmaceuticals and Medical Device Agency (PMDA) approval in Japan for the Farapulse pulsed field ablation (PFA) system. The...
medtronic

New clinical data show “excellent lesion durability” with Medtronic’s PulseSelect PFA...

Medtronic has announced the presentation of clinical study results demonstrating a high rate of durable lesion formation with the PulseSelect pulsed field ablation (PFA)...

PULSE-EU: single-shot spherical array PFA catheter achieves good clinical efficacy at...

The treatment of atrial fibrillation (AF) via a novel, ‘single-shot’ spherical array approach to pulsed field ablation (PFA) has been found to achieve durable...

Advertorial: PFA is now “beyond the phase of excitement”

This advertorial is sponsored by Boston Scientific The arrival of pulsed-field ablation (PFA) has been heralded by many experts in the field of arrhythmia management...

MANIFEST-17k registry shows promising safety performance for PFA

Pulsed field ablation (PFA) is safe for treating patients with common types of atrial fibrillation (AF), findings of the largest real-world registry of the...

Boston Scientific launches NAVIGATE-PF study

Boston Scientific has initiated the NAVIGATE-PF study of the Faraview software module when it is used to visualise and track the Farawave Nav pulsed...

Biosense Webster submits premarket approval application to US FDA for Varipulse...

Biosense Webster has submitted a premarket approval application (PMA) to the US Food & Drug Administration (FDA) for its Varipulse platform. The submission was...

“Second-generation” PFA catheter developer Field Medical closes seed round

Field Medical has closed its oversubscribed seed round with investments totalling US$14million. The convertible note funding was led by private investors who were joined by...

ADVERTORIAL: Pulsed field ablation: A new frontier in the treatment of...

This article was sponsored by Biosense Webster According to data published by Patrick M McCarthy (Feinberg School of Medicine, Chicago, USA) and colleagues in the...

HRS 2023: Late-breaking clinical trial results support PFA as treatment option...

New data from three late-breaking clinical trials has demonstrated the safety and efficacy of pulsed field ablation (PFA) as a viable, non-thermal treatment option...
Kardium Globe PFA

First patients treated in Kardium PULSAR IDE study of Globe pulsed...

Kardium, a private medical device company that has developed the Globe pulsed field (PF) system for the treatment of atrial fibrillation (AF) using pulsed...

AF Symposium hears late-breaking data from RFA and PFA trials

Biosense Webster has announced an update and late-breaking data from trials across radiofrequency ablation (RFA) and pulsed field ablation (PFA) at the 2023 AF...

Field Medical and CardioNXT to collaborate on 3D integrated PFA therapy

  Field Medical and CardioNXT have announced a strategic collaboration to provide the first-of-its-kind focal pulsed field ablation (PFA) therapy integrated with 3D mapping &...

Study reveals low reconnection rate with large antral lesion at PW...

A first-of-its-kind analysis on electrophysiological findings in patients with recurrent atrial tachyarrhythmia (ATa) following pulmonary vein isolation (PVI) using the novel pentaspline pulsed-field ablation...